Healthcare Sector

LLY

Market Tracker

$940.06
-15.13
(-1.58%)
8:00 pm
Next Earnings: (est.) 08/08/23 12:00 am
  • LLY (Selected)

    Eli Lilly and Company
  • LLYVA

  • LLYVK

  • LLYX

LLY Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

LLY Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

LLY Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

LLY Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

LLY Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

LLY Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
04/17/2026 CALL $1,000.00 4,042 +437 +12.12%
06/18/2026 CALL $1,050.00 947 +294 +45.02%
04/10/2026 CALL $950.00 804 +254 +46.18%
12/18/2026 CALL $1,200.00 878 +248 +39.37%
04/10/2026 PUT $840.00 780 +192 +32.65%
04/17/2026 CALL $1,100.00 3,365 +178 +5.59%
04/17/2026 CALL $920.00 219 -49 -18.28%
04/17/2026 PUT $1,060.00 83 -84 -50.30%
04/17/2026 CALL $1,040.00 2,586 -87 -3.25%
04/17/2026 CALL $955.00 399 -100 -20.04%
04/10/2026 CALL $1,000.00 3,538 -130 -3.54%
04/10/2026 CALL $980.00 769 -721 -48.39%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

LLY Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 2.74% 26M 11.45B
Vanguard 500 Index Fund 1.92% 18.23M 8.03B
Vanguard/Primecap Fund 1.56% 14.85M 6.54B
Fidelity 500 Index Fund 0.91% 8.65M 3.81B
SPDR S&P 500 ETF Trust 0.90% 8.54M 3.76B
Vanguard Specialized-Health Care Fund 0.80% 7.64M 3.37B
iShares Core S&P 500 ETF 0.74% 7.04M 3.1B
Washington Mutual Investors Fund 0.73% 6.95M 3.06B
Growth Fund Of America Inc 0.71% 6.7M 2.95B
Select Sector SPDR Fund-Health Care 0.67% 6.41M 2.82B

LLY News

  • Here's Why Buying This Vanguard Index Fund Today Could Be the Best Financial Decision You Ever Make

    04/10 03:15 pm

    The Motley Fool

    Read more
  • Atopic Dermatitis (7MM) Drug Market Forecast and Analysis Report 2023-2033: Opportunities Remain for the Treatment of AD, Novel Systemic Therapies Dominate the Late-stage Pipeline

    04/10 04:52 am

    GlobeNewswire Inc.

    Read more
  • Atopic Dermatitis 68-Market Drug Forecast and Market Analysis Report 2023-2025 & 2025-2033

    04/10 04:46 am

    GlobeNewswire Inc.

    Read more
  • Crohn's Disease Eight-Market Drug Forecast and Market Analysis Report 2025-2026: Novel MOAs Will Provide Market Shifts Throughout the Forecast Period to 2032

    04/10 04:43 am

    GlobeNewswire Inc.

    Read more
  • Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting

    04/09 07:00 am

    GlobeNewswire Inc.

    Read more
  • Eli Lilly Faces Pressure In India As Cheaper GLP-1 Rivals Dent Mounjaro Sales

    04/09 06:44 am

    Benzinga

    Read more
  • Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model

    04/09 02:00 am

    GlobeNewswire Inc.

    Read more
  • Nxera Pharma Achieves Second Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases

    04/08 07:34 pm

    GlobeNewswire Inc.

    Read more
  • ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event

    04/08 04:00 pm

    GlobeNewswire Inc.

    Read more
  • Looks Like M&A Week in 3 Different Sectors

    04/08 12:02 pm

    The Motley Fool

    Read more
  • Incyclix Bio Raises Additional $5 Million in Series B Financing to Advance Clinical Trial of INX-315 in Patients with CDK4/6 Inhibitor Resistant ER+/HER2- Breast Cancer or CCNE1-Amplified Solid Tumors

    04/08 07:00 am

    GlobeNewswire Inc.

    Read more
  • AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly

    04/07 07:00 am

    GlobeNewswire Inc.

    Read more
  • Trump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won’t Pay a Dime

    04/06 01:20 pm

    Investing.com

    Read more
  • Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight

    04/04 01:32 pm

    The Motley Fool

    Read more
  • Why Novo Nordisk's Pricing Shift Could Unlock a Much Larger Obesity Market

    04/03 05:02 pm

    The Motley Fool

    Read more
  • Where Will Viking Therapeutics Stock Be in 10 Years?

    04/03 03:26 pm

    The Motley Fool

    Read more
  • Deal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Considers Bankruptcy

    04/03 10:35 am

    Benzinga

    Read more
  • Dow, S&P 500, Nasdaq: From Morning Meltdown to Midday "Meh"

    04/02 02:25 pm

    The Motley Fool

    Read more
  • Lilly’s Next Empire: A $10 Billion Bet on AI and Neuroscience

    04/02 01:51 pm

    Investing.com

    Read more
  • Merck Just Made a Big Bet on a New Cancer Growth Engine

    04/02 11:32 am

    Investing.com

    Read more
  • Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report

    04/02 04:44 am

    Benzinga

    Read more
  • Prediction: This Will Be Eli Lilly's Next Billion-Dollar Growth Driver. (Hint: It's Not Weight Loss Drugs.)

    04/02 04:15 am

    The Motley Fool

    Read more
  • Why Eli Lilly Stock Trounced the Market Today

    04/01 06:23 pm

    The Motley Fool

    Read more
  • Stock Market Today, April 1: Markets Rally and Oil Prices Fall for Second Day Running

    04/01 05:21 pm

    The Motley Fool

    Read more
  • AAVantgarde appoints Philip Lao as Senior Vice President of Business Development

    04/01 07:00 am

    GlobeNewswire Inc.

    Read more
  • Nxera Pharma's Partner Centessa Pharmaceuticals to be Acquired by Lilly

    03/31 07:43 pm

    Benzinga

    Read more
  • Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly

    03/31 07:43 pm

    GlobeNewswire Inc.

    Read more
  • Trump Signals Iran Exit, S&P 500 Heads For Worst Month Since September 2022: What's Moving The Market On Tuesday?

    03/31 01:27 pm

    Benzinga

    Read more
  • Eli Lilly Expands Into Sleep Medicine With Centessa Buyout

    03/31 10:48 am

    Benzinga

    Read more
  • Stock Market Today, March 30: High Oil Prices Drive Risk-Off Sentiment, Nasdaq Falls 0.7%

    03/30 05:26 pm

    The Motley Fool

    Read more
  • Prediction: Buying Pfizer Stock Today Could Set You Up for Life

    03/29 08:15 pm

    The Motley Fool

    Read more
  • 1 Reason This Biotech Stock Could Triple Before Year-End

    03/29 12:30 am

    The Motley Fool

    Read more
  • Institutional Investors Are Selling One of Wall Street's Premier Trillion-Dollar Club Members (No, Not Nvidia!)

    03/27 05:06 am

    The Motley Fool

    Read more
  • Could Buying Eli Lilly Today Set You Up for Life?

    03/26 03:15 pm

    The Motley Fool

    Read more
  • SK pharmteco to Host Innovations in Pharmaceutical Manufacturing Symposium in Cambridge, Massachusetts

    03/26 10:00 am

    GlobeNewswire Inc.

    Read more
  • Sitryx to participate in upcoming April investor conferences

    03/26 07:00 am

    GlobeNewswire Inc.

    Read more
  • Is Novo Nordisk's Experimental Obesity Drug Outperforming Semaglutide?

    03/25 09:36 am

    Benzinga

    Read more
  • This Is the Most Important Thing Investors Can Do During a Volatile Market

    03/24 02:10 pm

    The Motley Fool

    Read more
  • Abivax CEO Downplays Sale Talk, Eyes Capital Raise As Key Trial Data Readout Nears

    03/24 01:53 pm

    Benzinga

    Read more
  • Eli Lilly To Phase Out Select Insulin Products Across Europe By 2027

    03/24 09:20 am

    Benzinga

    Read more
  • What's Going On With Eli Lilly On Monday?

    03/23 01:20 pm

    Benzinga

    Read more
  • Amphista Therapeutics announces three presentations at the American Association for Cancer Research Annual Meeting on its next-generation Targeted Glue™ degrader programs

    03/23 08:00 am

    GlobeNewswire Inc.

    Read more
  • Should You Buy Eli Lilly Stock Before April 10?

    03/22 05:10 am

    The Motley Fool

    Read more
  • My Top 3 Drug Stocks for March 2026

    03/20 06:30 am

    The Motley Fool

    Read more
  • 2 Healthcare Stocks to Buy Before They Get Bought Out

    03/20 05:34 am

    The Motley Fool

    Read more
  • Best Growth Stock to Buy Right Now: Eli Lilly vs. Vertex Pharmaceuticals

    03/19 02:30 pm

    The Motley Fool

    Read more
  • Eli Lilly Says Experimental Diabetes Drug Shows Weight Loss Of 17%

    03/19 11:37 am

    Benzinga

    Read more
  • Is It Too Late to Buy Eli Lilly?

    03/19 11:15 am

    The Motley Fool

    Read more
  • Ardsley Dumps 440,000 Hut 8 Shares Worth $19.4 Million

    03/18 12:21 pm

    The Motley Fool

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: